Skip to main content
. 2022 Dec 30;20(7):1800–1808. doi: 10.1111/ajt.15941

TABLE 2.

Initial hemodynamic and laboratory values among hospitalized patients with COVID-19

All (n = 68) Moderate disease (n = 41) Severe disease (n = 27) P-value
Vitals, median (IQR)
Maximum temperature (°C) 37.4 (37.1-37.9) 37.6 (37.1-38.1) 37.2 (36.7-37.4) .03
Heart rate (per min) 93.5 (83-104) 93 (85-106) 94 (80-101) .52
Respiratory rate (per min) 20 (18-24) 19 (18-21) 22 (19-39.5) .01
Lowest O2 sat (%) 94 (91-96) 95 (92-96) 91 (88-94) .01
Blood counts, median (IQR)
WBC × 1000/μL 5.16 (3.5-7.5) 5.66 (3.67-7.4) 4.4 (2.5-10.43) .63
Hgb g/dL 11.2 (9.4-12.6) 11.4 (10.2-12.9) 9.8 (8.9-12.2) .20
Platelets × 1000/μL 176.5 (129-221) 174 (138-221) 186 (124-215) .95
Neutrophils count/μL 3.8 (1.92-5.68) 4.1 (2.02-5.42) 3.64 (1.62-7.27) .96
Lymphocytes count/μL 0.7 (0.34-1.09) 0.7 (0.39-1.04) 0.80 (0.14-1.26) .83
Neutrophil to lymphocyte ratio 5.27 (2.89-9.46) 5.14 (3.23-8.39) 6.22 (1.97-14.17) .70
INR, median (IQR) 1.1 (1-1.2) 1.1 (1-1.2) 1.2 (1.1-1.4) .06
Chemistries, median (IQR)
Creatinine, mg/dLa 1.89 (1.15-3.85) 1.9 (1.15-3.47) 1.9 (1.47-3.96) .41
Albumin g/dL 3.6 (3.1-3.9) 3.8 (3.2-4) 3.35 (2.75-3.7) .048
AST U/L 26 (17-36) 24.5 (18-34) 33 (17-48) .39
ALT U/L 18 (13-25) 18 (12-25) 18 (14-24) .51
Total bilirubin mg/dL 0.4 (0.3-0.5) 0.4 (0.3-0.5) 0.5 (0.4-0.6) .04
Additional labs, median (IQR)b
HS-troponin ng/L 27 (9-58.5) 17.5 (8.5-43.5) 52.5 (9.5-77) .24
Procalcitonin ng/mL 0.285 (0.15-0.86) 0.205 (0.12-0.7) 0.73 (0.37-3.795) .003
CRP mg/L 68.5 (15.445-126) 60 (11-110) 97 (18.6-130) .20
d-dimer μg/mL 1.335 (0.69-3.08) 1.04 (0.66-1.96) 2.2 (0.99-3.81) .13
Ferritin ng/mL 801.5 (270-1514) 813 (257-1611) 790 (466-1464) .86
IL-6 level pg/mL 20 (8-51) 18 (5-45) 32 (11-90) .26
a

Six patients were on chronic renal replacement therapy and not included in this calculation.

b

These values were not available for all patients (HS-troponin N = 44, procalcitonin N = 50, CRP N = 48, D-dimer N = 40, ferritin N = 46, IL-6 N = 33).